About Pancreatic Cancer
Overview of Pancreatic Cancer
Pancreatic cancer is currently the fourth leading cause of cancer deaths in the United States. The American Cancer Society estimates that in 2018; 55,440 Americans will be diagnosed with pancreatic cancer in the U.S., and over 44,330 will die from pancreatic cancer. One of the major challenges associated with pancreatic cancer is that the condition often goes undetected for a long period of time because signs and symptoms seldom occur until advanced stages. By the time symptoms occur, cancer cells are likely to have spread (metastasized) to other parts of the body, often preventing surgical removal of tumors.
Pancreatic cancer is a major focus of cancer research, and much progress is being made in understanding the risks for pancreatic cancer, diagnosing and treating it, and the genetics behind the condition. Pancreatic cancer research funding has increased almost 400% since 2000, when only $22 million was spent on research, to $99.5 million in 2011. Research findings and advancements are being published on an ongoing basis, helping to advance medical knowledge and improve patient quality of life.
To read more, please click on the following:
(Hosted by the National Pancreas Foundation, Memorial Sloan-Kettering, and Johns Hopkins)